devinitorg/iati-policy-markers huggingface dataset:
NIHR GRP: Developing a melioidosis vaccine targeted for people with type 2 diabetes in Low- and Middle-income countries The NIHR Global Research Professorship scheme is open to all professions and all Higher Education Institutions (HEI), based in England and the Devolved Administrations, to nominate health researchers and methodologists with an outstanding research record of clinical and applied health research and its effective translation for improved health. Global Research Professors are required to have existing strong collaborations or links with collaborators or partners in institutions in countries on the OECD DAC list and the award should plan to strengthen these/support training and capacity development/mentorship in these partners.Melioidosis is a grossly under-recognised tropical disease, caused by bacterium in the soil. Most people with melioidosis are poor and live in rural regions, typically working in rice farming. Ubon in Northeast Thailand is a world hotspot for melioidosis. More than half of melioidosis patients have diabetes, which is rising rapidly in low- and middle-income countries. This research will conduct the world’s first clinical trial of a new vaccine to prevent melioidosis, targeted for people with diabetes in Thailand and other tropical regions. The laboratory research carried out will identify which biomarkers to use to monitor how the vaccine works in Thailand, and study why people with diabetes are at a greater risk of infections compared to other people. The aims of the research are to: 
1.)	evaluate the safety and immunogenicity of a vaccine for melioidosis in people with diabetes in Oxford, UK, and compare immunogenicity with healthy non-diabetic subjects 
2.)	evaluate the safety and immunogenicity of a vaccine for melioidosis in people with and without diabetes in Ubon Ratchathani, Thailand, and compare immunogenicity with UK subjects 
3.)	define the key biomarkers for future monitoring of efficacy of the vaccine for melioidosis using an existing melioidosis patient cohort study 
4.)	undertake a community consultation activity to explore perceptions, understanding and key sensitivities amongst people with diabetes in Ubon, Thailand toward participation in future efficacy trials of a melioidosis vaccine
NIHR HPSR-DA: Strengthening health systems in South Africa to achieve universal health coverage for people with stroke In South Africa(SA), stroke is a leading cause of death and disability and over 30,000 people have a stroke each year. Stroke incidence is increasing due to rising prevalence of risk factors such as obesity and hypertension. While efforts are made to prevent stroke, provision of stroke care remains largely unmet and where available, is limited in quality and accessibility. We will establish a SA-UK partnership to build a consortium, drawing together people with stroke, their families, rural communities, health professionals, researchers and policy planners, which can inform policy makers on context-appropriate stroke care for the new universal health coverage(UHC) bill in SA. Together, we will consider: (i)healthcare needs of people with stroke (ii)how the Health System can meet these needs through a people-centred approach. Our findings will identify priorities for research, generate recommendations for health system planners and inform a subsequent Research Program 1) Establish a Stellenbosch University (SU) and London School of Hygiene & Tropical Medicine (LSHTM) partnership to build a consortium (3-5 institutions) to identify and address research priorities to improve stroke care in SA
2)Determine the current provision of healthcare for people with stroke in SA
3)Identify appropriate economic evaluation methods for a future Research Program
Within two provinces purposively selected for comparison, the Eastern Cape (the poorest) and the Western Cape (second wealthiest), our objectives are to:
4)Interrogate networks of health service provision for people with stroke
5)Determine the needs of people with stroke and their families in accessing health services
European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2017 work plan The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty-related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2017 Workplan focussed on: ‘Strategic Actions Supporting Large-Scale Clinical Trials’ and ‘Clinical Trials to reduce health inequities in pregnant women, newborns and children’. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). 1) support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, diagnostics, vaccines, microbicides) for poverty related diseases; 2) accelerate the adaption and/or optimisation of treatment and prevention products (excluding vaccines) for povertyrelated diseases in sub-Saharan Africa for use in pregnant women, newborns and/or children.
NIHR GRP: Mitigating Chronic Respiratory Disease through the lens of Multi-Morbidity AIM: The scientific challenge I will address is how to better identify people living with chronic respiratory diseases (CRDs) in low- and middle-income countries (LMICs). Specifically, I will demonstrate the ability to reliably identify previously un-diagnosed CRDs in people attending clinics for other conditions such as high-blood pressure and diabetes in San Carlos, Brazil. I will also demonstrate that identifying chronic obstructive pulmonary disease (COPD) and asthma in this way benefits those affected and society. This project has 5 aims:

AIM-1: Determine the patterns and time-sequence of acquiring other medical conditions in people with chronic respiratory diseases (CRDs). This will be achieved by applying a novel mathematical approach to our existing, large random population dataset of 10,664 people.

AIM-2: Assess the accuracy of simple chronic obstructive pulmonary disease (COPD) case-finding questionnaires to find people with un-diagnosed CRDs in community-based high-blood pressure and/or diabetes clinics in Brazil. We will enrol 859 people from such clinics, use casefinding questionnaires to measure CRD risk, and compare this against a gold-standard diagnosis using spirometry.

AIM-3: Assess if CRD case-finding questionnaires can be successfully used by clinicians in community high-blood pressure and/or diabetes clinics in Brazil. We will ask four clinicians at each of five clinics to use the questionnaire in 50 patients each (1,000 people in total). We will test how well they use the questionnaire and ask about ease of use.

AIM-4: Investigate whether people identified using case-finding questionnaires as being at high-risk for CRDs in high-blood pressure and/or diabetes clinics are able to access health-care. We will re-contact people identified in AIMS 2 and 3 as being at high-risk for CRDs to see if they were able to access a confirmatory diagnosis and treatment six months later.

AIM-5: Determine whether optimisation of care in people found to have COPD and asthma through case-finding is associated with improvement in their health and benefit to society. For people confirmed as having COPD and asthma in AIMS 3 and 4, we will recommend optimal care and measure health-status before and after six months. We will collect information on costs to tell us whether such an approach could be cost effective at scale.
NIHR HPSR-DA: Co-developing an Evidence-based Plan to Strengthen the Health Care System and Inform Policy to Reduce Cancer Burden in Mongolia Mongolia has the highest cancer death rates in Asia-Pacific and cancer incidence is expected to double by 2040. The proposed study represents the first step of a health policy and systems research (HPSR) programme aiming to reduce cancer burden in Mongolia by strengthening its health care system and supporting evidence-based service planning and policy development. Collaborative preliminary work identified cancer prevention and early detection as the early focus of the HPSR Programme. In this developmental phase we will work with local stakeholders to describe current early detection and cancer prevention initiatives in Mongolia, and to identify and develop plans for future HPSR research and capacity building activities. We will conduct a scoping review, undertake a needs-and-gaps analysis, use consensus-elicitiation techniques to identify priorities, provide capacity-building training in Mongolia and the UK, and co-develop plans to advance our collaborative HPSR programme. 1) Conduct a review of published and grey literature regarding early detection and cancer prevention in Mongolia
2) Undertake a needs-and-gaps analysis (key informant interviews, online survey, consensus workshop) to identify, refine and prioritise research questions
3) Design an interdisciplinary collaborative research programme focusing on improving early detection and cancer prevention in Mongolia
4) Establish a community advisory steering group to contextualise and sustain the partnership and assist with dessimination of research results into usable findings
5) Develop and expand (according to HSPR Programme needs) the current Queens University Belfast (QUB)-National Cancer Centre of Mongolia (NCC) partnership
6) Contribute to capacity building, skill development and knowledge transfer
7) Formulate and sign a Memorandum of Understanding between QUB and NCC.
Diagnostics, Prosthetics and Orthotics to Tackle Health Challenges in Developing Countries The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Engineering and Physical Sciences Research Council (EPSRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to EPSRC, which makes onwards disbursements to awardees. This research call is a high quality programme of research centred on innovative healthcare technologies, to tackle the challenges faced by low- and middle-income countries. Proposals must address one of the two priority areas: (1) low cost, rapid, point of care imagine and diagnostic technologies; (2) affordable prosthetics and orthotics. The overall aim of this call is to develop frugal innovation approaches for healthcare technologies in specific priority areas, which have the potential to revolutionise care pathways in low and middle income countries (LMICs). Such technologies must be developed in partnership with teams from LMICs, and have the delivery of impactful, cost-effective, culturally acceptable, and sustainable welfare and economic benefits within LMICs as their primary objective.
NIHR Global Health Research Units and Groups: research call 1 The NIHR's first Global Health Research call for Units and Groups. UK universities and research institutes were invited to submit applications, working in equitable partnerships with researchers in low- and middle-income countries (LMICs), to either expand (Units) or develop (Groups) their ambitions to deliver world-class applied global health research to address under-funded or under-researched global health areas specific to those countries. 1) Deliver the UK's ambition to be internationally outstanding in global health research, improving the lives of people in LMICs. 2) Create an environment where world-class global health research, focused on the needs of LMICs can thrive. 3) Translate advances in applied global health research into benefits for patients and the public in LMICs. 4) Focus on priority areas which will have the greatest impact on health in LMICs in the short, medium and long term. 5) Provide high quality research evidence to inform decision-making by public health officials, practitioners and policy makers. 6) Increase the volume and quality of multi-disciplinary global health research from the UK. 7) Develop knowledge and capacity within existing UK institutions which can be translated into global health research practice. 8) Retain a level of responsive research capacity to address emerging global health research requirements (Units only).
NIHR Global Health Research Group on Improving Stroke Care A UK and low- and middle-income country (LMIC) partnership that aims to improve stroke care in acute settings. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. NIHR Global Health Research Group on Improving Stroke Care objectives: 1) Create a partnership of clinicians, academics, patients and the public in India to develop research capacity to support innovation in healthcare in order to improve the management of stroke. 2) Develop effective ways of working together to prioritise, develop, deliver and implement research. 3) Engage with key stakeholders in healthcare in India to ensure that our research is relevant, important, accessible and practically focused. 4) Build sustainability for health research by supporting people and organisations to develop research, by building systems to facilitate research, and by capturing funding to support work to continue beyond the end of the project. 5) Identify key transferable knowledge for potential implementation in other settings and relevant health conditions.
NIHR RIGHT1: Epilepsy Pathway Innovation in Africa (EPInA) A UK and low- and middle-income country (LMIC) research partnership that aims to address the diagnosis, treatment and understanding of epilepsy in Ghana, Kenya and Tanzania. PREVENT: reduce the incidence of infection and peri-natal injury in an endemic region in Tanzania and the subsequent risk of epilepsy.  
DIAGNOSE: improve the rate of accurate diagnosis of epilepsy by developing app-based technologies.  
TREATMENT: increase the adherence to medication using text messaging. 
SOCIETAL CHANGE: ensure an enduring, positive change by improving public awareness and reducing the stigma experienced by people with epilepsy in Sub Saharan Africa.
National Institute for Health and Care Research (NIHR)’s sixth Global Research Professorship call National Institute for Health and Care Research (NIHR)’s sixth Global Research Professorship call. The Global Research Professorships programme funds research leaders, with a track-record of applied health research in low- and middle-income countries (LMICs), to promote effective translation of research and to strengthen research leadership at the highest academic levels. Funding of up to £2m over up to 5 years is awarded to Professors working in close partnership with a research institution in an LMIC. By the end of the award, NIHR Global Research Professors will be expected to: 

1) Have demonstrated research leadership at a national and/or international level.
2) Have been developed and protected by their institutions, including being relieved of administrative tasks.
3) Enhance existing and establish new research collaborations in low- and middle-income countries (LMICs).
4) Have supported training and capacity strengthening/mentorship within LMIC and UK (if applicable) institutions that enhances research capacity for future global health and care research.
NIHR HPSR-DA: Post-tuberculosis lung damage amongst pulmonary tuberculosis survivors in East Africa: health system challenges and research priorities Current guidelines for tuberculosis (TB) management focus on microbiological cure and survival, with no follow-up of patients beyond TB treatment completion. However, data suggest that TB survivors have a high burden of disabling residual lung damage, recurrent TB disease, and increased rates of mortality. There is an unmet need to develop post-TB care pathways to improve the long-term wellbeing of TB survivors. Clinical tools for post-TB care are under development. However, existing health systems in East Africa are poorly equipped to deliver these services and there has been little planning of how post-TB care could be achieved. This project will build on the partnership between London School of Tropical Medicine (LSTM) and African Institute for Development Policy (AFIDEP) to engage stakeholders in Malawi and Kenya in order to review existing management practices, and outline potential models of post-TB care for the region. This work will form the basis of future large-scale funding applications, and policy and implementation work. 1. Consolidate the existing academic partnership between Liverpool School of Tropical Medicine (LSTM) and the African Institute for Development Policy (AFIDEP)
2. Develop relationships with the wider policy-making and academic community working in post-tuberculosis (TB) care in the region
3. Perform a systematic review of post-TB management guidelines and practices in the region
4. Engage in dialogue with in-country stakeholders in Kenya and Malawi to identify potential models of post-TB care, barriers to implementation, and existing data gaps.
Global Alliance for Chronic Diseases Associate Membership contribution The Global Alliance for Chronic Diseases (GACD) funds implementation research to generate new knowledge on interventions and their implementation for the prevention or management of chronic non-communicable diseases (NCDs). As an Associate Member of the alliance, the Department of Health and Social Care (DHSC) pays an annual fee to support the activities of the GACD. This activity is a component of the Global Alliance for Chronic Diseases programme, GB-GOV-10-GACD. 1. To tackle the burden of chronic non-communicable diseases (NCDs), by systematically building the evidence base for sound policymaking.
2. Ensure a common understanding of health priorities as well as bigger impact of the collective actions of the Global Alliance for Chronic Diseases (GACD).
3. Joint development and management of funding opportunities and research programmes
4. Coordination of research priorities to avoid the potential duplication of efforts and enable a better focus on research areas where the need for evidence to inform policy, programmes and practice is most urgent.
5. Foster research partnerships to enable knowledge sharing and capacity building
NIHR Global Health Research Group on Depression and Anxiety in Youth in African Countries - “African Youth in Mind” African Youth in Mind (AYMI) will bring together researchers, youth and a range of government and non-government stakeholders to learn how best to treat depression and anxiety in youth aged 15-24 in Ghana and Zimbabwe. We will build capacity on youth-focussed mental health interventions in these two countries and also in Malawi. 
Depression and anxiety prevent youth from productivity and innovation and from reaching their full educational and social potential.  This is critical in African countries, where 60% of the population are aged under 25. Depression and anxiety are key risk factors for self-harm and for suicide, which is the third leading cause of death globally in this age group.  Various treatments which help with thinking, behaviour and emotions are known to be able to restore health and functioning for depressed and anxious youth. These could feasibly be delivered by non-specialists in low-resource settings.
Our plan is to work with youth and caregivers to adapt and test a stepped care intervention for youth with depression and anxiety, which is tailored to the needs of communities in Ghana and Zimbabwe. We will build on lessons from African innovation, especially the Zimbabwean Friendship Bench. Based on country priorities and context, we will shape the intervention in Ghana for those aged 15-18 enrolled in Ghana’s free senior high school system and in Zimbabwe for youth aged 15-24 in schools, colleges and community health settings including sexual health services. We will then evaluate the clinical and economic benefits of the intervention through running a clinical trial in senior high schools in Ghana. 
By the end of our program, we aim to have four completed PhDs for African early career researchers in youth mental health (in Zimbabwe, Ghana, and Malawi), two post-doc fellowships completed, and ten publications in open access journals, with at least 80% of these to be first or senior authored by an African researcher. Our longer-term vision is a strong interdisciplinary group of African-UK researchers in youth mental health, and for our stepped care intervention to be taken up by governments and NGOs to improve youth mental health. 1. To provide essential context about needs and strengths of youth and of organisations and systems supporting youth in our research communities.                                      
2. Develop and agree implementation theory for delivering youth mental health interventions, and the pathway to primary mental health care and specialist care for youth with more complex needs.
3. Inform content and implementation of relevant interventions, and measurement of clinical outcomes.
4. Learn about youth and caregiver views of mental health and mental health interventions.
Global Road Safety Facility (GRSF) The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The World Bank’s Global Road Safety Facility aims to address the growing public health crisis of road traffic deaths and injuries in low- and middle-income countries (LMICs) through supporting the scale-up of scientific, technological and managerial capacities to effectively manage road safety. 1) Fund applied research grants under the UN’s five pillars for road safety: Road Safety Management, Safer Roads and Mobility, Safer Vehicles, Safer Road Users, Post-Crash Response. 2) Improve global road safety data collection 3) Increase knowledge and evidence base to support policy interventions